The market size for Penicillins and Streptomycins in dosage per capita in Armenia saw fluctuations between 2013 and 2023. Notably, the value per capita decreased from $2.27 in 2013 to $1.75 in 2023. The year-on-year change shows a decline of 2.8% from 2022 to 2023, and a significant 5-year CAGR shows an annual average decline of 1.04% in value per capita.
Future trends to watch for include potential impacts from healthcare policy changes and the introduction of alternative antibiotics or generic drug competition, which may continue to influence the market's decline and reshape demand dynamics in Armenia.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 24 | 24 Brazil | 2.01 | 2023 | View data | ||
| 25 | 25 Malaysia | 1.87 | 2023 | View data | ||
| 26 | 26 Armenia | 1.75 | 2023 | |||
| 27 | 27 Kyrgyzstan | 1.57 | 2023 | View data | ||
| 28 | 28 Estonia | 1.55 | 2023 | View data | ||
